| 2836.92.00 | 00 | Strontium carbonate | kg | 4.2% | Free (A,AU,BH, CA,CL,E, IL,J,JO, MA,MX,P,SG) | 25% |
| 2923.20.10 | 00 | Purified egg phospholipids, pharmaceutical grade meeting requirements of the U.S. Food and Drug Administration, for use in intravenous fat emulsion | kg | Free | | 16.5￠/kg + 30% |
| 2932.11.00 | 00 | Compounds containing an unfused furan ring (whether or not hydrogenated) in the structure: | | | | |
| 2933.11.00 | 00 | Compounds containing an unfused pyrazole ring (whether or not hydrogenated) in the structure: | | | | |
| 2933.21.00 | 00 | Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure: | | | | |
| 2933.31.00 | 00 | Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure: | | | | |
| 2933.41.00 | 00 | Compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused: | | | | |
| 2933.52 | | Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure: | | | | |
| 2933.61.00 | 00 | Compounds containing an unfused triazine ring (whether or not hydrogenated) in the structure: | | | | |
| 2934.10 | | Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure: | | | | |
| 2934.20 | | Compounds containing in the structure a benzothiazole ring-system (whether or not hydrogenated), not further fused: | | | | |
| 2934.30 | | Compounds containing in the structure a phenothiazine ring-system (whether or not hydrogenated), not further fused: | | | | |
| 2937 | | Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: | | | | |
| 2937.11.00 | 00 | Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: | | | | |
| 2937.11.00 | 00 | Somatotropin, its derivatives and structural analogues | g | Free | | 10% |
| 2937.21.00 | | Steroidal hormones, their derivatives and structural analogues: | | | | |
| 2937.23 | | Estrogens and progestins: | | | | |
| 2937.23.10 | 10 | Estrogens | g | | | |
| 2937.23.25 | 00 | Estradiol benzoate; and Estradiol cyclopentylpropionate (Estradiol cypionate) | g | Free | | 15.4￠/kg + 49% |
| 2937.23.50 | 10 | Estrogens | g | | | |
| 2937.31.00 | 00 | Catecholamine hormones, their derivatives and structural analogues: | | | | |
| 2937.50.00 | 00 | Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues | g | Free | | 25% |
| 2939.11.00 | 00 | Concentrates of poppy straw; buprenorphine (INN); codeine, dihydrocodeine (INN), ethylmorphine, etorphine (INN), heroin, hydrocodone (INN), hydromorphone (INN), morphine, nicomorphine (INN), oxycodone (INN), oxymorphone (INN), pholcodine (INN), thebacon (INN) and thebaine; salts thereof | kg | Free | | 15.4￠/kg + 50% |
| 2941.10 | | Penicillins and their derivatives with a penicillanic acid structure; salts thereof: | | | | |
| 2941.20 | | Streptomycins and their derivatives; salts thereof: | | | | |
